Bullous Diseases

Contributing journals to this collection:
JAMA & Archives Journals

Citations 101-110 of 144 total displayed.

Past content

Critical Situations
Aggressive Immunosuppressive Therapy for a Refractory Case of IgA Pemphigus

Kendall Sibley Hash; Adrienne Rencic; Maria Ines Hernandez; Takashi Hashimoto; H. Carlos Nousari
Arch Dermatol 2002; 138: 744-746. [Extract] [Full text] [PDF]  

Consensus Statement
The First International Consensus on Mucous Membrane Pemphigoid: Definition, Diagnostic Criteria, Pathogenic Factors, Medical Treatment, and Prognostic Indicators

Lawrence S. Chan; A. Razzaque Ahmed; Grant J. Anhalt; Wolfgang Bernauer; Kevin D. Cooper; Mark J. Elder; Jo-David Fine; C. Stephen Foster; Reza Ghohestani; Takashi Hashimoto; Thanh Hoang-Xuan; Gudula Kirtschig; Neil J. Korman; Susan Lightman; Francina Lozada-Nur; M. Peter Marinkovich; Bartly J. Mondino; Catherine Prost-Squarcioni; Roy S. Rogers III; Jane F. Setterfield; Dennis P. West; Fenella Wojnarowska; David T. Woodley; Kim B. Yancey; Detlef Zillikens; John J. Zone
Arch Dermatol 2002; 138: 370-379. [Abstract] [Full text] [PDF]  

Evidence-Based Dermatology: Original Contributions
Interventions for Mucous Membrane Pemphigoid/Cicatricial Pemphigoid and Epidermolysis Bullosa Acquisita: A Systematic Literature Review

Gudula Kirtschig; Dédée Murrell; Fenella Wojnarowska; Nonhlanhla Khumalo
Arch Dermatol 2002; 138: 380-384. [Abstract] [Full text] [PDF]  

Evidence-Based Dermatology: Original Contributions
A Systematic Review of Treatments for Bullous Pemphigoid

Nonhlanhla P. Khumalo; Dedeé F. Murrell; Fenella Wojnarowska; Gudula Kirtschig
Arch Dermatol 2002; 138: 385-389. [Abstract] [Full text] [PDF]  

Editorials
Treatment Considerations While Awaiting the Ideal Bullous Pemphigoid Trial

Diya F. Mutasim
Arch Dermatol 2002; 138: 404. [Extract] [Full text] [PDF]  

Observations
Clinical and Serological Transition From Pemphigus Vulgaris to Pemphigus Foliaceus Demonstrated by Desmoglein ELISA System

Yukiko Tsuji; Toshimitsu Kawashima; Koichi Yokota; Yasuki Tateish; Yuki Tomita; Tetsuri Matsumura; Hiroshi Shimizu
Arch Dermatol 2002; 138: 95-96. [Extract] [Full text] [PDF]  

The Cutting Edge
Infliximab (Anti–Tumor Necrosis Factor Antibody): A Novel, Highly Effective Treatment of Recalcitrant Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease)

Constanze Voigtländer; Matthias Lüftl; Gerold Schuler; Michael Hertl
Arch Dermatol 2001; 137: 1571-1574. [Extract] [Full text] [PDF]  

Comments, Opinions, and Brief Case Reports
Subcutaneous Nodules After a Cat Bite

A. Javier Trujillo-Santos; F. Aguiar-García; C. González-Hermoso
Arch Intern Med 2001; 161: 2043-2044. [Extract] [Full text] [PDF]  

Studies
Comparison Between Intravenous Immunoglobulin and Conventional Immunosuppressive Therapy Regimens in Patients With Severe Oral Pemphigoid: Effects on Disease Progression in Patients Nonresponsive to Dapsone Therapy

A. Razzaque Ahmed; José E. Colón
Arch Dermatol 2001; 137: 1181-1189. [Abstract] [Full text] [PDF]  

Studies
Detection of IgA Autoantibodies to Desmogleins by an Enzyme-Linked Immunosorbent Assay: The Presence of New Minor Subtypes of IgA Pemphigus

Takashi Hashimoto; Ayako Komai; Yuko Futei; Takeji Nishikawa; Masayuki Amagai
Arch Dermatol 2001; 137: 735-738. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15